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EDITORIAL 
Polyamines in Psoriasis 
Psorias is is a ve ry common, complex, inheri ted systemic metabolic 
disease having mul t iple etiologic factors in te racting to produce cha r-
acteristic cutaneous les ions. Al t hough t he most common recognizable 
lesions occur on t he skin , other body t issues including t hose of t he 
cardiovascula r system, the gastrointestinal system (including liver), 
a nd the skeleta l system are very often involved. P robably because of 
t he va riabili ty and mul t iplicity of etiologic facto rs, t here is no other 
common sk in disease t hat taxes one's therapeut ic abili t ies as does the 
d isease, psorias is. T he enormous va riety of therapeut ic agents and 
r egimens t hat have been developed and devised are testimony to t he 
lack of susta ined efficacy a nd/ or unwanted toxicity experienced with 
m ost. 
In recent years, considerable research has produced a large body of 
information o!Jering clues to t he etiology and pathogenesis of psorias is. 
If we exa mine closely the morphologic picture presented by a typical 
p so riasis plaque, we find that it occurs as t he end resul t of hyperproli -
feration a nd inflammation. Epidermal disease is characterized by in -
c reased cellula r proliferation. In t he typical cutaneous plaque of pso-
rias is, t he number of proliferating cells wi t hin t he epidermis is in-
c reased up to 12- fold greater than in normal skin . Even in t he unin -
volved skin of patients wi th psorias is, t he number of proliferating cells 
w it hin t he epidermis is increased up to two a nd one- half t imes greater 
t han in the skin of nonpsoriatics. The mi totic index of t he epidermis 
in involved skin is increased up to 1000 t imes greater t han in normal 
s kin . In the dermis of the psoriasis plaque, inf1ammation a nd vascular 
injury predominate. Of importance in the pathogenesis of epidermal 
a nd dermal disease are abnormali t ies of cyclic nucleotide, polyamine 
a nd of the by- products of a rachidonic ac id metabolism principally 
prostaglandins and leukotrienes [1- 5]. It appears t hat in t he presence 
o f increased qua ntities of polyamines, prostagla ndins, and leukotrienes, 
e piderma l cell nucleic ac id synthesis (DNA) a nd epidermal cell prolif-
e ration are increased. In the dermis, increased quant it ies of t hese 
s ubstances are associated with increased vascula r permeability, disper-
s ion of polymorphonuclear leucocytes (both epidermal and dermal), 
a nd derma l accumula t ion of fluid. 
In t his issue of t he J ournal, McCullough et al report some very 
in te resting a nd potent ia lly significant findings on polyamine levels in 
injury-stimulated epide rmis and on inhibito rs of polyamine synt hesis. 
Their findings, which may eventually be applicable in t he t reatment of 
psorias is, extend and corroborate t he observations of other investiga-
to rs [6,7]. Before considering t he significance of McCullough's report , 
i t is most appropriate to summa rize t he present state of our knowledge 
o f polyamines a nd t heir role as growt h promoters, particula rly in 
p sorias is. 
Polyamines, spermidine a nd spermine, are rather ubiquitous a nd are 
found in significant a mounts in virtually all mammalian cells, as well 
as in bac teria, parasitic protozoa and t he like. They are also probably 
required for in t racellula r viral replication. T he chemical structure of 
t he polyamines, spermidine a nd spermine, as well as t he precursor 
dia mine, put rescine, a re shown in Fig 1. The principle pathway of 
polyamine synt hesis in mamma lian cells is demonstrated in Fig 2. 
Alt hough the exact phys iologic function of t he polyamines remains 
e lusive a nd is not well understood at t he molecula r level, it is generally 
acknowledged that norma l cellular growt h a nd different iation require 
p olyamines [8]. In t his discussion, our attent ion will be focused on t he 
s ignificance of t hese substances on cellula r growt h rather t han differ-
e nt iation. 
Tissue a nd cellular quant ities of polyamines a nd their precursor, 
put rescine, have been found substant ially elevated in live r regenerating 
a fter partial hepatectomy; in skin and leukemic ce lls afte r the appli -
cation of tumor promoters, such as t he phorbolesters; in skin following 
U VB irradiation; a nd in s kin stimulated by ha ir plucking [8- 10]. 
R ussell et al have found polyamine levels to be higher in the involved 
s kin of patients wi th pso rias is t ha n in un involved skin [11] . Polyamine 
levels were a lso found to be higher in t he uninvolved skin of psoriasis 
p at ients than in the normal skin of individuals wi t hout pso rias is. These 
data correlate well wi th information previously cited on t he nature of 
cell proliferation in psoriasis in involved and noninvolved skin. Urina ry 
polyamine levels a re a lso higher in patients wit h psoriasis t han in 
normal individuals. 
Increased cellula r levels of polyamines have been previously associ-
ated wit h increased levels of DNA synt hesis and increased cellular 
replication [12]. T opical spermine and put rescine have caused stimu -
lated DNA synthesis in ha irless mouse epidermis [13]. In psorias is, 
increased polyamine synt hesis and DNA synt hesis precede t he state of 
hyperproli fe ration a nd disturbed keratinization. Increased levels of 
ornit hine decarboxylase, the rate- limi t ing enzyme in polyamine biosyn-
t hesis, have been demonstrated in states of hyperproliferation as in 
psorias is. 
Inhi bito rs of polyamine synt hesis, i.e., substances such as methyl-
glyoxal-bis-(guanylhydrazone) (M GBG), a-methylornit hine a nd a -di -
fluoromethylorni t hine which inhibit certa in enzymatic steps in t he 
polyamine biosynt hetic pathway (Fig 2), a lso cause reductions in DNA 
synthesis a nd cellula r replication in vit ro and in psoriat ic skin. This 
inhibito ry effect is reversed by t he addi t ion of polyamines. T he exact 
mechanism whereby polyamines affect nucleic ac id metabolism is un -
known a nd t he role of polyamine metabolism in t he pathophysiology 
of psoriasis cannot, as yet , be fully defin ed. Yet, t he accumulation of 
polyamines in psorias is a nd t heir normalization wit h t reatment suggest 
t he involvement of polyami nes in t he pathophysiology of psorias is. One 
earlier postulated mechanism of polyamine effect on DNA synt hesis is 
diagrammed in Fig 2. Recent findings may cast some doubt on t his 
mechanism since it now appears t hat increases in t issue cyclic AMP 
levels may precede increases in polyamine levels. It has previously been 
shown t hat psorias is lesions have a reduced cyclic AMP / cyclic G MP 
ratio and t hat age nts which cause elevation of t issue cyclic AMP levels 
can improve psorias is lesions. 
What is t he significance of t he observat ions of McCullough a nd his 
coworkers? Why are t hese observations of significance in t he realm of 
psoriasis therapy? Since Gubner's fortui t ious observation t hat psorias is 
responds to t he administration of systemic agents t hat inhibit nucleic 
acid synthes1s a nd cell replication, most research in psoriasis t herapeu-
t ics has cente red a round t he development of specific inhibitors of 
nucleic ac id synthesis [14]. P robably because of t heir ready availabil ity 
as cancer chemotherapeut ic agents, most ant ipsorias is drugs have 
tended to come from groups of nonselective cytotoxics, and have 
required systemic administration. Among the most efficaceous agents 
a re methotrexate, hydroxyurea, t riacetyl-6-azauridine, mycophenolic 
ac id, 6- mercaptopurine-azathioprine, and 5-fluorouracil. Unfortu-
nate ly, wi th t he except ion of mycophenolic ac id, t hese agents a re 
nonselective in their effects; they a re cytotox ic to all t issues in which 
rapid cellular replication is taking place, a nd have severe and, at t imes, 
life-threatening adverse effects in organ systems other t han t he skin . 
Numerous attempts at formulating topically applicable and effective 
forms of t he present ly ava ilable nucleic ac id inhibito rs have been most 
unsuccessful. Wi t h few except ions, topica l formulations have shown 
li ttle or no effect on psoriasis plaques when applied directly to t he skin . 
Lack of effect in t hese circumstances probably relates to a number of 
ill -defin ed facto rs such as poor percutaneous penetration (inabili ty of 
the formulated substance to penetrate t he epiderma l ba rrier layer); 
drug instabili ty when applied to t he skin; absence of specific drug-
activating enzymes in the epidermis; inappropriate vehicle a nd many 
more. Some agents such as topical ni t rogen musta rd and 5-fluorouracil , 
alt hough active in topical form , have proved too tox ic and irritating 
when applied over prolonged periods directly to t he skin. In a series of 
earlier experiments designed to ident ify a group of agents which may 
prove of some use when applied to active psorias is plaques, Weinstein , 
McCullough, a nd others observed that MGBG , a n inhibito r of polyam-
ine biosynt hesis, was moderate ly effective in controlling the cutaneous 
lesions of psorias is [14]. Grosshans and others demonstrated a marked 
reduction in diamine and polyamine production afte r two weeks' t reat-
ment of psoriatic's skin wit h difluoromethylorni thine, a n irreversible 
inhibito r of orni t hine decarboxylase [5]. In their most recent report, 
McCullough a nd Weinstein , as have other investigato rs, have shown 
t hat topically applied MGBG can, in fact, reduce polyamine synt hesis 
and ultimately epidermal DNA synt hesis (Fig 3) and epiderma l ce ll 
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FIG 1. Structural formulae of t he polya mines and t he related diamine. 
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FIG 2. Pathway of polyamine synthesis and postulated effect on cell rep lication. In this scheme, increased levels of polyamines inhibi t adenyl 
cyclase activity and t he formation of cyclic AMP which, in turn, resul ts in increased cell replication. 
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F IG 3. Postulated interaction of polya mines, inhibitors of polyami ne synthesis, and cell replication. Blocking agents: 1 = a-difluoromethylor-
ni t hine; 2 = a:-methylorni thine; 3 = a-ethylornithine; 4 = methylglyoxal-bis-(guanylhydrazone). 
rep lication. T opica lly applied glucocorticoids a nd anthra li n, PUVA, 
and retinoids have a lso been found to reduce epiderma l polyamine 
synthesis and cell replication . Although t hese findin gs do not ult imately 
answer the questions relative to the specific role of polyamines in the 
regu lation of growth in psoriat ic t issue, t hey do take us a step fur t her 
along in t he development of a group of topical agents which may prove 
to be effective a nd revo lutionary in the control of cuta neous psorias is. 
Some newer polyamine antagon ists such as DFMO, (\'- methylorni thine, 
(\'-et hylnori t hine, a -hydrazono-li -aminova leric ac id, and 5- hexynel-4-
diam ine may singly or in combination, exert a n even more profound 
effect on polyamine synthesis and cell replication in psoriasis. There 
is no question t hat the safest method of t reating a skin disease is via 
t he application of effect ive a nd nontoxic topical substances to the skin . 
In psorias is therapy, effective topical agents would relieve the therapist 
of the need to use toxic systemic agents, reserving their use only fo r 
t hose individuals found to have significant systemic disease. 
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